Disease Awareness and Prescription Drug Communications on Television CDER researchers conducted two experimental studies among adult asthma patients to determine how the similarity, proximity (how close […]

Background When promoting a new drug, a pharmaceutical company may release disease awareness communications about the disease a new drug is intended to treat. Disease awareness […]

Summary Company Announcement Date: July 16, 2024 FDA Publish Date: July 16, 2024 Product Type: Dietary SupplementsDrugs Reason for Announcement: Recall Reason Description Tainted with the […]

For Immediate Release: July 16, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the […]

HOW TO USE THIS SNAPSHOTThe information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, […]

2023 NDA Drug Name Purpose Approval Date  NDA 17031/S-041 Opill (norgestrel) tablet, 0.075 mg Prevention of pregnancy AP 7-13-23 NDA 208411/S-006 Narcan (naloxone hydrochloride, 4 mg) […]

On This Page Date: September 4, 2024 Time: 11:00 AM – 3:00 PM ET Agenda Visit CDER Small Business and Industry Assistance Page ABOUT THIS EVENT […]

Applying for Membership on FDA Advisory Committees As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of […]

Delivery Method: UPS Next Day Signature Required Product: Drugs Recipient: Recipient Name Mr. Moisei Reyzis Recipient Title President Art of Beauty Company, Inc. 200 Egbert RoadBedford, […]